Incyte Reports 2015 First-Quarter Financial Results and Updates Shareholders on Key Clinical Programs

Go back to Incyte Reports 2015 First-Quarter Financial Results and Updates Shareholders on Key Clinical Programs
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 104.40 --0 (-0%)
Previous Close $104.40    52 Week High $118.49 
Open $104.40    52 Week Low $55.00 
Day High $104.40    P/E N/A 
Day Low $104.40    EPS $-0.56 
Volume 18